How do successful companies identify market growth opportunities across healthcare systems? The emergence of new data sets and new technology together allow companies to pinpoint opportunities much more efficiently than before, increasing their competitiveness and allowing them to understand their markets and customers to a degree that wasn’t possible even three years ago.

Saudi Arabia is currently undergoing a significant restructuring of its healthcare sector, resulting in disruption for healthcare MNCs. The implementation of national health insurance is leading to an increased focus on cost containment, while the launch of healthcare clusters raises questions about the future role of NUPCO. Firms are also grappling with how to engage with the Health Holding Company, as well as seeking more clarity on the implementation of health technology assessment.

As healthcare MNCs push technological boundaries to address more complicated healthcare challenges, it is becoming increasingly important to build innovative methods to overcome tight payer budgets and growing uncertainty around potential clinical outcomes (accentuated by contradictory incentive structures and a lack of disease and technology awareness in many cases).

While China had a late start in implementing DRG payment models, it has made remarkable progress in the last three years, with the inception of its own DIP model, rapid implementation in pilot cities, and diverse subnational policy initiatives aimed at integrating the new payment model with other ongoing reform agendas. In 2024, we expect a steady expansion of DRG/DIP adoption.

The global pandemic created a new reality and fundamentally changed the way healthcare companies engage with stakeholders across the healthcare ecosystem. For companies to stay relevant and competitive in the post-pandemic world, hybrid engagement, a strategic and balanced approach that combines both analog and digital engagement methods, is imperative.

Pharmaceutical and medical device companies are confronting rising uncertainty in key markets in Latin America, as leftist governments attempt to overhaul healthcare systems and, in some cases, industrial policy. The likely revival of localization policies by the Lula administration is driving increasing concern, particularly for pharmaceutical companies.

While congressional debates for Colombia’s healthcare reform launch in February, there is an increased urgency to monitor risks and business implications for 2023. In this webinar, FrontierView’s Latin America healthcare team will facilitate a conversation to provide scenarios for outcomes of a healthcare reform. We will focus our discussion on proposals that drastically change the role of HMOs.

2022 was a turning point for the Russian healthcare market, which moved from “full of opportunities” to “full of questions.” Will cuts in the public budget affect market opportunities? What do changes in the Circle of Kindness fund and other funding sources mean? In this webinar, FrontierView’s discusses the major questions confronting pharmaceutical and medical device decision makers in 2023.

The ongoing energy crisis and persistently high inflation continue to have ripple effects on healthcare spending in Central Europe amid challenging macroeconomic, geopolitical, and governance environments in 2023, provoking a variety of questions among decision makers. What are the real increases in healthcare expenditures? In this webinar, our healthcare research team shares insights on Central European countries in 2023.

Mexico’s healthcare system will find itself in the middle of yet another transition in 2023–2024, attempting to improve its scorecard on progress made in the last few years. In this webinar, FrontierView analysts will discuss the outlook for the transition to IMSS-Bienestar, the consolidated purchase process, and potential impacts for the industry in 2023–2024.

More than a year after reaching an 80% vaccinated population, Brazil’s healthcare system continues to grapple with long patient wait lists and limited financing to address the monumental backlogs left behind by the COVID-19 pandemic. In this webinar we provide an update on healthcare recovery in Latin America’s largest market.

Latin America is facing a crisis concerning the diagnosis and treatment of cancer patients.  Join our LATAM healthcare research team for this webinar as we discuss key common trends across LATAM markets and highlight the most important updates within the oncology space across your top countries.

Gustavo Petro, a long-time proponent of sweeping healthcare reform in Colombia, took a prominent lead in the March 2022 primaries, suggesting healthcare disruptions during the next administration. During this webinar, FrontierView analysts will discuss the outlook for the election and the potential impacts for the industry.

FrontierView’s team presents a look at Asia Pacific’s demand recovery in the medium and long terms, along with the implications for funding, market access, and reimbursement dynamics. Our discussion will center on how to drive healthcare spending to be a priority and consider medium-term demand and funding outlooks for China, Japan, India, and emerging ASEAN.

Our APAC healthcare analysts will walk you through the healthcare policy and expenditure outlooks for India and Southeast Asia’s emerging healthcare markets in 2022, sharing our expectations for the macroeconomic conditions, healthcare funding dynamics, and policy initiatives that will shape performance in these key markets.

Our APAC healthcare analysts will walk you through the healthcare policy and expenditure outlooks for Japan, South Korea, and Australia in 2022, discussing our expectations for the macroeconomic conditions, healthcare funding dynamics, and policy initiatives that will shape performance in these key markets.

As you set your demand expectations for next year, let our APAC healthcare analysts guide you through our healthcare policy and expenditure outlook for Q4 2021 and 2022 for China. This webinar outlines our initial expectations for 2022, including COVID-19 pandemic management and vaccination timelines.

We’d like to welcome you to an interactive webinar on the healthcare policy and expenditure outlook for the major emerging healthcare markets of ASEAN. FrontierView’s research team will share our revised expectations for the region’s diverse healthcare landscape, as governments across the region balance combating COVID-19 with pursuing long-term healthcare policy priorities.

The Turkish economy will grow around 4% in 2021, with a relatively more stable lira, high interest rates, and most importantly for the healthcare sector, a higher fiscal deficit and public debt levels. Political tensions, weak confidence in the Turkish lira, potential delays in vaccination timelines due to supply shortages are all risks executives will need to monitor.

We’d like to welcome you to an interactive webinar on the healthcare policy and expenditure outlook for China. FrontierView’s research team will share our revised expectations for China’s healthcare landscape, as the reimbursement outlook achieves normalization and healthcare authorities pursue deepening healthcare reforms.

FrontierView’s research team shares our revised expectations for Japan and South Korea’s healthcare landscape over the coming months, as these governments confront a challenging winter, seek to rollout COVID-19 vaccines, and support other healthcare spending priorities.

We’d like to welcome you to an interactive webinar on the healthcare policy and expenditure outlook for India. FrontierView’s research team will share our revised expectations for India’s healthcare landscape through FY 2021-2022.